Raymond C. Bergan

Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833.

P. Choyke, T. Fojo, S. Bates, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer.

O. Sartor, W. Figg, E. Reed, 1995, The American journal of medicine.

Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.

S. Steinberg, E. Sausville, O. Sartor, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.